BioAlg
BioAlg provides an AI-driven platform that lets researchers test how drugs perform in virtual patients. It uses AI-generated digital twins, ML models, and computer experiments to simulate clinical trials and predict molecule effects, a B2B SaaS solution designed for end users. Core tech includes digital twin generation, state-of-the-art AI/ML algorithms, and gold-standard datasets to drive accurate simulations. It targets pharmaceutical R&D teams and CROs seeking faster, risk-reduced trial design with a user-friendly interface that requires no IT background. The platform aims to broaden trial insights at scale and optimize protocols to improve success rates.
BioAlg
BioAlg provides an AI-driven platform that lets researchers test how drugs perform in virtual patients. It uses AI-generated digital twins, ML models, and computer experiments to simulate clinical trials and predict molecule effects, a B2B SaaS solution designed for end users. Core tech includes digital twin generation, state-of-the-art AI/ML algorithms, and gold-standard datasets to drive accurate simulations. It targets pharmaceutical R&D teams and CROs seeking faster, risk-reduced trial design with a user-friendly interface that requires no IT background. The platform aims to broaden trial insights at scale and optimize protocols to improve success rates.